We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
37 hedge funds and large institutions have $329M invested in Evelo Biosciences, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
186% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 7
6% more capital invested
Capital invested by funds: $312M → $329M (+$17.5M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
14% less funds holding
Funds holding: 43 → 37 (-6)
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Holders
37
Holders Change
-6
Holders Change %
-13.95%
% of All Funds
0.85%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
1
Increased
20
Reduced
7
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$5.86M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.26M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$1.44M |
| 4 |
State Street
Boston,
Massachusetts
|
+$697K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$512K |
